195 related articles for article (PubMed ID: 22586795)
1. The urticarias: pathophysiology and management.
Grattan C
Clin Med (Lond); 2012 Apr; 12(2):164-7. PubMed ID: 22586795
[No Abstract] [Full Text] [Related]
2. Urticaria and Angioedema: an Update on Classification and Pathogenesis.
Radonjic-Hoesli S; Hofmeier KS; Micaletto S; Schmid-Grendelmeier P; Bircher A; Simon D
Clin Rev Allergy Immunol; 2018 Feb; 54(1):88-101. PubMed ID: 28748365
[TBL] [Abstract][Full Text] [Related]
3. A patient with steroids and antihistaminic drug allergy and newly occurred chronic urticaria angioedema: what about omalizumab?
Kutlu A; Karabacak E; Aydin E; Ozturk S; Bozkurt B
Hum Exp Toxicol; 2014 Aug; 33(8):882-5. PubMed ID: 24203455
[TBL] [Abstract][Full Text] [Related]
4. [Argentine guidelines for urticaria and angioedema].
Máspero J; Cabrera H; Ardusso L; De Gennaro M; Fernández Bussy R; Galimany J; Galimberti D; Label M; La Forgia M; Medina I; Neffen H; Troielli P; ;
Medicina (B Aires); 2014; 74 Suppl 1():1-53. PubMed ID: 25202880
[TBL] [Abstract][Full Text] [Related]
5. Omalizumab markedly improves urticaria activity scores and quality of life scores in chronic spontaneous urticaria patients: a real life survey.
Büyüköztürk S; Gelincik A; Demirtürk M; Kocaturk E; Colakoğlu B; Dal M
J Dermatol; 2012 May; 39(5):439-42. PubMed ID: 22221177
[TBL] [Abstract][Full Text] [Related]
6. A critical appraisal of omalizumab as a therapeutic option for chronic refractory urticaria/angioedema.
Lang DM
Ann Allergy Asthma Immunol; 2014 Apr; 112(4):276-9. PubMed ID: 24589165
[No Abstract] [Full Text] [Related]
7. Omalizumab for chronic urticaria.
Casale TB
J Allergy Clin Immunol Pract; 2014; 2(1):118-9. PubMed ID: 24565785
[No Abstract] [Full Text] [Related]
8. JID VisualDx Quiz: January 2015.
Shabbir A; Kirsner RS
J Invest Dermatol; 2015 Jan; 135(1):1-2. PubMed ID: 25501381
[No Abstract] [Full Text] [Related]
9. Angioedema is an unfavorable factor for the response to omalizumab in chronic spontaneous urticaria: A retrospective study.
Serarslan G; Uzun M; Doğramacı AÇ; Çelik E
Dermatol Ther; 2019 Jan; 32(1):e12752. PubMed ID: 30238582
[TBL] [Abstract][Full Text] [Related]
10. Chronic urticaria.
Zuberbier T
Curr Allergy Asthma Rep; 2012 Aug; 12(4):267-72. PubMed ID: 22638841
[TBL] [Abstract][Full Text] [Related]
11. [Urticaria and angioedema in children].
Hestholm F; Morken T; Skadberg BT; Berg A
Tidsskr Nor Laegeforen; 2002 Feb; 122(6):610-4. PubMed ID: 11998713
[TBL] [Abstract][Full Text] [Related]
12. Pathogenic intracellular and autoimmune mechanisms in urticaria and angioedema.
Altman K; Chang C
Clin Rev Allergy Immunol; 2013 Aug; 45(1):47-62. PubMed ID: 22674016
[TBL] [Abstract][Full Text] [Related]
13. Prevention of anaphylaxis related to mast cell activation syndrome with omalizumab.
Bell MC; Jackson DJ
Ann Allergy Asthma Immunol; 2012 May; 108(5):383-4. PubMed ID: 22541416
[No Abstract] [Full Text] [Related]
14. Omalizumab in chronic urticaria.
Metz M; Maurer M
Curr Opin Allergy Clin Immunol; 2012 Aug; 12(4):406-11. PubMed ID: 22766620
[TBL] [Abstract][Full Text] [Related]
15. Omalizumab is an effective and rapidly acting therapy in difficult-to-treat chronic urticaria: a retrospective clinical analysis.
Metz M; Ohanyan T; Church MK; Maurer M
J Dermatol Sci; 2014 Jan; 73(1):57-62. PubMed ID: 24060603
[TBL] [Abstract][Full Text] [Related]
16. The potential pharmacologic mechanisms of omalizumab in patients with chronic spontaneous urticaria.
Chang TW; Chen C; Lin CJ; Metz M; Church MK; Maurer M
J Allergy Clin Immunol; 2015 Feb; 135(2):337-42. PubMed ID: 24948369
[TBL] [Abstract][Full Text] [Related]
17. The anti-IgE antibody omalizumab as a probe to investigate the role of IgE in pathology.
Mauro M; Incorvaia C; Formigoni C; Elia R; Russello M; Pellegrino D
Panminerva Med; 2012 Dec; 54(4):305-12. PubMed ID: 23123583
[TBL] [Abstract][Full Text] [Related]
18. Omalizumab in chronic spontaneous urticaria: patient-tailored tapering or planned discontinuation?
Tontini C; Marinangeli L; Cognigni M; Bilò MB; Antonicelli L
Ann Allergy Asthma Immunol; 2015 Aug; 115(2):147-8. PubMed ID: 26048249
[No Abstract] [Full Text] [Related]
19. Aspirin desensitization achieved after omalizumab treatment in a patient with aspirin-exacerbated urticaria and respiratory disease.
Guillén D; Bobolea I; Calderon O; Fiandor A; Cabañas R ; Heredia R; Quirce S
J Investig Allergol Clin Immunol; 2015; 25(2):133-5. PubMed ID: 25997307
[No Abstract] [Full Text] [Related]
20. Treatment of chronic autoimmune urticaria with omalizumab.
Kaplan AP; Joseph K; Maykut RJ; Geba GP; Zeldin RK
J Allergy Clin Immunol; 2008 Sep; 122(3):569-73. PubMed ID: 18774392
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]